Physician profile
Hani B Baradi
NPI 1194782912
$23,152.79
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,386 · 2020: $8,418 · 2021: $12K · 2022: $297 · 2023: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $87.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $87.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,947.50 | 2019-2021 | |
| Medtronic USA, INC. | $247.73 | 2019-2020 | |
| Allergan, INC. | $221.41 | 2019-2022 | |
| Ethicon US, LLC | $148.03 | 2019-2023 | Echelon Circular |
| Medtronic, INC. | $120.90 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $81.47 | 2021-2023 | Myrisk |
| Merck Sharp & Dohme LLC | $56.59 | 2022 | |
| Abbvie INC. | $49.16 | 2022 | |
| Covidien LP | $40.96 | 2019 | |
| Zyla Life Sciences, INC. | $38.17 | 2019-2020 | |
| Tela Bio, INC. | $31.07 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Olympus America INC. | $29.91 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $29.77 | 2019-2022 | |
| Acera Surgical, INC. | $27.99 | 2022 | |
| Cook Medical LLC | $18.33 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17.68 | 2021 | |
| Mallinckrodt Enterprises LLC | $16.96 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hani Baradi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.